文献速递神经儿科影像MR

儿童脑T1信号测量:非神经疾病多次暴露钆贝葡胺后的表现

T1 Signal Measurements in Pediatric Brain: Findings after Multiple Exposures to Gadobenate Dimeglumine for Imaging of Nonneurologic Disease.
PubMed 文献 · AJNR Am J Neuroradiol · 2017-06-22

该研究比较了34例接受5~15次0.05 mmol/kg钆贝葡胺注射的非神经疾病儿童与24例从未接受钆对比剂的对照儿童,在非增强T1加权图像上测量齿状核、苍白球、脑桥和丘脑的信号强度及比值。结果显示两组信号强度及齿状核-脑桥比值无显著差异,仅一名阅片者发现苍白球-丘脑比值差异,但反映的是对照组丘脑信号非显著升高。结论认为多次低剂量钆贝葡胺暴露后未见到提示钆沉积的信号强度增加。

要点

  • 儿童非神经疾病患者多次暴露于低剂量钆贝葡胺后,非增强T1加权图像上齿状核、苍白球、脑桥和丘脑信号强度与未暴露对照组无显著差异。
  • 仅一名阅片者发现苍白球-丘脑信号强度比值差异,但该差异反映对照组丘脑T1信号非显著升高,并非暴露组信号增高。
  • 暴露次数和首次至末次暴露间隔均未影响信号强度值。

核心结论

  • 儿童非神经疾病患者多次暴露于低剂量钆贝葡胺后,未见到可能提示钆沉积的信号强度增加。

研究设计与样本

  • 回顾性比较研究,纳入34例非神经疾病患者(组1,17男/17女,平均年龄7.18岁),接受5至15次(平均7.8次)0.05 mmol/kg钆贝葡胺注射,平均暴露时间2.24年;对照组24例(组2,16男/8女,平均年龄8.78岁)从未接受钆对比剂;5名盲法阅片者独立测量两组非增强T1加权自旋回波图像上齿状核、苍白球、脑桥和丘脑ROI的信号强度;采用非配对t检验比较组间信号强度值及齿状核-脑桥、苍白球-丘脑信号强度比值。

诊断标准与关键数值

  • 组1齿状核、苍白球、脑桥、丘脑平均信号强度值范围分别为366.4~389.2、360.5~392.9、370.5~374.9、356.9~371.0,组2对应值无显著差异(P > .05)。
  • 各阅片者比较齿状核-脑桥信号强度比值均未发现显著差异。
  • 一名阅片者发现苍白球-丘脑平均信号强度比值差异(1.06 ± 0.006 vs 1.02 ± 0.009,P = .002),但反映对照组丘脑T1信号非显著升高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Signal intensity increases possibly suggestive of gadolinium retention have recently been reported on unenhanced T1-weighted images of the pediatric brain following multiple exposures to gadolinium-based MR contrast agents. Our aim was to determine whether T1 signal changes suggestive of gadolinium deposition occur in the brains of pediatric nonneurologic patients after multiple exposures to gadobenate dimeglumine.

MATERIALS AND METHODS: Thirty-four nonneurologic patients (group 1; 17 males/17 females; mean age, 7.18 years) who received between 5 and 15 injections (mean, 7.8 injections) of 0.05 mmol/kg of gadobenate during a mean of 2.24 years were compared with 24 control patients (group 2; 16 males/8 females; mean age, 8.78 years) who had never received gadolinium-based contrast agents. Exposure to gadobenate was for diagnosis and therapy monitoring. Five blinded readers independently determined the signal intensity at ROIs in the dentate nucleus, globus pallidus, pons, and thalamus on unenhanced T1-weighted spin-echo images from both groups. Unpaired t tests were used to compare signal-intensity values and dentate nucleus-pons and globus pallidus-thalamus signal-intensity ratios between groups 1 and 2.

RESULTS: Mean signal-intensity values in the dentate nucleus, globus pallidus, pons, and thalamus of gadobenate-exposed patients ranged from 366.4 to 389.2, 360.5 to 392.9, 370.5 to 374.9, and 356.9 to 371.0, respectively. Corresponding values in gadolinium-based contrast agent-naïve subjects were not significantly different (P > .05). Similarly, no significant differences were noted by any reader for comparisons of the dentate nucleus-pons signal-intensity ratios. One reader noted a difference in the mean globus pallidus-thalamus signal-intensity ratios (1.06 ± 0.006 versus 1.02 ± 0.009, P = .002), but this reflected nonsignificantly higher T1 signal in the thalamus of control subjects. The number of exposures and the interval between the first and last exposures did not influence signal-intensity values.

CONCLUSIONS: Signal-intensity increases potentially indicative of gadolinium deposition are not seen in pediatric nonneurologic patients after multiple exposures to low-dose gadobenate.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Schneider GK, Stroeder J, Roditi G, et al. T1 Signal Measurements in Pediatric Brain: Findings after Multiple Exposures to Gadobenate Dimeglumine for Imaging of Nonneurologic Disease. AJNR Am J Neuroradiol. 2017. PMID: 28642266. doi:10.3174/ajnr.A5270

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。